Skip to Content
Morningstar

ALPS Medical Breakthroughs ETF SBIO

Morningstar Medalist Rating
Medalist Rating as of | See ALPS Investment Hub

Morningstar’s Analysis SBIO

Will SBIO outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable SBIO’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the SBIO management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of SBIO’s parent organization’s priorities and whether they’re in line with investors’ interests.

Weakness in ALPS Medical Breakthroughs ETF's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SBIO

More SBIO Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 32.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cerevel Therapeutics Holdings Inc Ordinary Shares

5.11 5.3 Mil
Healthcare

Viking Therapeutics Inc

4.72 4.9 Mil
Healthcare

Vaxcyte Inc Ordinary Shares

4.57 4.7 Mil
Healthcare

Revolution Medicines Inc Ordinary Shares

4.10 4.2 Mil
Healthcare

Alpine Immune Sciences Inc

2.86 3.0 Mil
Healthcare

Alkermes PLC

2.71 2.8 Mil
Healthcare

Crinetics Pharmaceuticals Inc

2.32 2.4 Mil
Healthcare

Axsome Therapeutics Inc

2.23 2.3 Mil
Healthcare

SpringWorks Therapeutics Inc Ordinary Shares

2.20 2.3 Mil
Healthcare

Xenon Pharmaceuticals Inc

2.12 2.2 Mil
Healthcare